ClinConnect ClinConnect Logo
Search / Trial NCT06182475

Development and Test of a Communication Skills Training for Transplant Providers - Aims 2 & 3

Launched by TEMPLE UNIVERSITY · Dec 12, 2023

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Patient Provider Communication Live Donor Kideny Transplantation Provider Training Communication Skills Training

ClinConnect Summary

This clinical trial is focused on improving communication between kidney transplant providers and patients, specifically looking at how Black and Caucasian patients interact with their healthcare team during transplant evaluations. The researchers want to understand what types of communication are most effective in helping patients feel comfortable and informed about their options for living donor kidney transplants. The goal is to develop training programs for transplant providers to enhance their communication skills, which could lead to better outcomes for patients seeking transplants.

To participate in the study, individuals must be at least 18 years old, self-identify as Black or Caucasian, speak English, and attend a kidney transplant evaluation at specific hospitals. Participants will be asked to complete brief surveys before and after their consultations and allow their meetings to be recorded for research purposes. The findings will help determine how well providers communicate and whether improved communication leads to more inquiries and evaluations for living donor transplants. It's important to note that this trial is not currently recruiting participants.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • (1) appear for a kidney transplant evaluation at Cooperman Barnabas Medical Center (CBMC) or Temple University Hospital (TUH)
  • (2) speak English
  • (3) be of self-reported Black or Caucasian ethnicity
  • (4) be ≥18 years of age.
  • Including patients who:
  • 1. have received prior kidney transplants
  • 2. patients with limited English proficiency, as long as they speak with the physician via a translator
  • 3. patients evaluated at offsite satellite locations that are not actually at CBMC or TUHS.
  • All transplant nephrologists, nurses, and social workers employed at the kidney transplant programs at CBMC and TUH who are actively involved in patient evaluations for transplant will be eligible for participation in the study. Providers refusing to permit digital audio recording of the transplant consultation will be deemed ineligible.
  • Exclusion Criteria:
  • (1) are non-verbal or otherwise unable to converse with providers
  • (2) are already listed for kidney transplant at CBMC or TUHS or at another transplant center
  • (3) have limited English proficiency and speak directly with the physician in a language other than English.
  • Patients having (1) received an offer to donate a kidney from a family member or friend, or (2) explicitly asked a family member or friend to consider serving as a LD will be excluded, along with any patients refusing to permit digital audio recording of the transplant consultation will also be deemed ineligible to participate.
  • The following special populations will be excluded: adults unable to consent, individuals who are not yet adults (infants, children, teenagers), prisoners, and individuals who do not understand English.
  • It is unlikely that any female patient will be pregnant while awaiting kidney transplant; however, we will not exclude pregnant women.

About Temple University

Temple University is a leading academic institution located in Philadelphia, Pennsylvania, renowned for its commitment to research and innovation in the health sciences. As a clinical trial sponsor, Temple University leverages its extensive resources, including a diverse pool of participants and cutting-edge facilities, to advance medical knowledge and improve patient care. The university's clinical research initiatives are driven by a multidisciplinary team of experts dedicated to conducting high-quality studies that address critical health issues and contribute to the development of novel therapies. Through its partnerships with local and global organizations, Temple University aims to enhance the translation of research findings into practical applications that benefit communities and advance public health.

Locations

Philadelphia, Pennsylvania, United States

Livingston, New Jersey, United States

Patients applied

0 patients applied

Trial Officials

Francis Weng, MD

Principal Investigator

St. Barnabas Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported